Bailard’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-200,000
| Closed | -$1.8M | – | 778 |
|
|
2021
Q3 | $1.8M | Sell |
200,000
-79,100
| -28% | -$713K | 0.06% | 209 |
|
|
2021
Q2 | $3.34M | Sell |
279,100
-43,500
| -13% | -$521K | 0.12% | 155 |
|
|
2021
Q1 | $4.04M | Sell |
322,600
-69,700
| -18% | -$873K | 0.15% | 136 |
|
|
2020
Q4 | $6.12M | Buy |
392,300
+22,200
| +6% | +$346K | 0.28% | 79 |
|
|
2020
Q3 | $3.5M | Sell |
370,100
-34,900
| -9% | -$330K | 0.18% | 106 |
|
|
2020
Q2 | $3.63M | Sell |
405,000
-46,000
| -10% | -$412K | 0.2% | 94 |
|
|
2020
Q1 | $2.87M | Buy |
451,000
+255,900
| +131% | +$1.63M | 0.2% | 99 |
|
|
2019
Q4 | $1.63M | Sell |
195,100
-55,000
| -22% | -$460K | 0.09% | 168 |
|
|
2019
Q3 | $2.26M | Buy |
250,100
+74,500
| +42% | +$674K | 0.14% | 146 |
|
|
2019
Q2 | $1.89M | Buy |
175,600
+19,500
| +12% | +$210K | 0.12% | 163 |
|
|
2019
Q1 | $1.49M | Buy |
156,100
+123,100
| +373% | +$1.17M | 0.09% | 190 |
|
|
2018
Q4 | $379K | Sell |
33,000
-121,500
| -79% | -$1.4M | 0.03% | 367 |
|
|
2018
Q3 | $2.62M | Buy |
154,500
+77,000
| +99% | +$1.31M | 0.15% | 137 |
|
|
2018
Q2 | $1.1M | Buy |
77,500
+57,500
| +288% | +$817K | 0.07% | 210 |
|
|
2018
Q1 | $380K | Buy |
+20,000
| New | +$380K | 0.02% | 381 |
|